Labeling of Oxidizable Proteins with a Photoactivatable Analog of the Antitumor Agent DMXAA: Evidence for Redox Signaling in Its Mode of Action
The signaling pathway(s) and molecular target(s) for 5,6-dimethylxanthenone-4-acetic acid (DMXAA), a tumor vascular disrupting agent in late stages of clinical development, are still undefined. As an approach toward identifying potential targets for DMXAA, a tritiated azido-analog of DMXAA was used...
Main Authors: | Romy Brauer, Liang-Chuan S. Wang, See-Tarn Woon, David J.A. Bridewell, Kimiora Henare, Dieter Malinger, Brian D. Palmer, Stefanie N. Vogel, Claudine Kieda, Sofian M. Tijono, Lai-Ming Ching |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2010-09-01
|
Series: | Neoplasia: An International Journal for Oncology Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1476558610800776 |
Similar Items
-
Neutrophil Influx and Chemokine Production during the Early Phases of the Antitumor Response to the Vascular Disrupting Agent DMXAA (ASA404)
by: Liang-Chuan S. Wang, et al.
Published: (2009-08-01) -
Vascular disrupting agent DMXAA enhances the antitumor effects generated by therapeutic HPV DNA vaccines
by: Hung Chien-Fu, et al.
Published: (2011-03-01) -
Evaluation of Novel Inhibitors of Tryptophan Dioxygenases for Enzyme and Species Selectivity Using Engineered Tumour Cell Lines Expressing Either Murine or Human IDO1 or TDO2
by: Sofian M Tijono, et al.
Published: (2022-08-01) -
Discovery of Novel STING Inhibitors Based on the Structure of the Mouse STING Agonist DMXAA
by: Jiajia Chang, et al.
Published: (2023-03-01) -
Photoactivatable BODIPYs for Live-Cell PALM
by: Yang Zhang, et al.
Published: (2023-03-01)